![]() |
市場調査レポート
商品コード
1738336
植物由来添加剤市場- 世界の産業規模、シェア、動向、機会、予測、種類別、用途別、地域別、競合別、2020-2030年Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F |
||||||
カスタマイズ可能
|
植物由来添加剤市場- 世界の産業規模、シェア、動向、機会、予測、種類別、用途別、地域別、競合別、2020-2030年 |
出版日: 2025年05月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2~3営業日
|
植物由来添加剤の世界市場は、2024年には21億4,000万米ドルと評価され、2030年には27億4,000万米ドルに達し、CAGR 4.21%で成長すると予測されています。
この市場は、製薬業界を中心に、合成賦形剤に代わる天然で持続可能な代替品へのシフトが進むにつれて勢いを増しています。デンプン、ガム、セルロース、タンパク質、藻類など再生可能な資源に由来する植物由来の賦形剤は、医薬品製剤の溶解性、安定性、バイオアベイラビリティを高めると同時に、世界の持続可能性の目標に合致しています。これらの賦形剤はより安全で反応性が低く、副作用のリスクを低減し、合成汚染物質を含まないクリーンなプロファイルを提供すると考えられています。クリーンラベルで環境に優しい製剤に対する消費者の嗜好と、天然成分に対する規制上の奨励の高まりが、採用に拍車をかけています。さらに、環境意識の高まりと、世界の主要地域における政府の持続可能性イニシアティブが相まって、予測期間中に植物由来賦形剤の需要がさらに伸びることが予想されます。
市場概要 | |
---|---|
予測期間 | 2026-2030 |
市場規模:2024年 | 21億4,000万米ドル |
市場規模:2030年 | 27億4,000万米ドル |
CAGR:2025年~2030年 | 4.21% |
急成長セグメント | フィルム形成・コーティング剤 |
最大市場 | 北米 |
クリーンラベルおよび天然医薬品成分に対する需要の高まり
原料品質のばらつきとサプライチェーンの混乱
生物製剤とバイオシミラーにおける植物由来賦形剤の統合
The Global Plant Based Excipients Market was valued at USD 2.14 billion in 2024 and is projected to reach USD 2.74 billion by 2030, growing at a CAGR of 4.21%. This market is gaining momentum as industries, especially pharmaceuticals, shift toward natural and sustainable alternatives to synthetic excipients. Derived from renewable sources such as starches, gums, cellulose, proteins, and algae, plant-based excipients enhance the solubility, stability, and bioavailability of drug formulations while aligning with global sustainability goals. These excipients are considered safer and less reactive, reducing the risk of adverse side effects, and they offer a cleaner profile free from synthetic contaminants. Consumer preference for clean-label, eco-friendly formulations and increasing regulatory encouragement for natural ingredients are fueling adoption. Additionally, rising environmental awareness, coupled with government-backed sustainability initiatives across key global regions, is expected to support further growth in demand for plant-derived excipients over the forecast period.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 2.14 Billion |
Market Size 2030 | USD 2.74 Billion |
CAGR 2025-2030 | 4.21% |
Fastest Growing Segment | Film Forming & Coating Agents |
Largest Market | North America |
Key Market Drivers
Rising Demand for Clean Label and Natural Pharmaceutical Ingredients
A major growth driver in the Plant Based Excipients Market is the rising preference for clean-label and naturally derived pharmaceutical ingredients. Consumers are becoming more attentive to the composition of drugs and supplements, prompting pharmaceutical and nutraceutical companies to incorporate excipients derived from natural sources like gums, cellulose, and starch. These plant-based substances are perceived as safer and more environmentally friendly compared to synthetic or animal-based alternatives. Regulatory authorities, such as the FDA and EMA, promote ingredient transparency and emphasize safety profiling, indirectly supporting the adoption of plant-derived excipients. Clean-label trends are also reinforced by regulations aimed at reducing synthetic additive use, especially in Europe. As companies aim to meet consumer expectations and regulatory requirements, the demand for clean, sustainable excipients is increasing, driving growth in this market.
Key Market Challenges
Variability in Raw Material Quality and Supply Chain Disruptions
The plant-based excipients market faces challenges related to the inconsistency in raw material quality, which can impact formulation reliability and drug performance. Since these excipients are extracted from agricultural sources, their composition may vary depending on environmental conditions such as climate, soil type, and pest exposure. This natural variability can complicate efforts to maintain consistent pharmaceutical standards for bioavailability, stability, and shelf life. Additionally, disruptions in the global supply chain-caused by climate change, pandemics, or geopolitical issues-can result in shortages or increased costs of key raw materials. For example, the COVID-19 pandemic exposed vulnerabilities in sourcing and logistics for agricultural products, further highlighting risks in maintaining a steady supply of plant-based ingredients. These factors can deter manufacturers from fully transitioning to plant-derived excipients, especially in high-precision drug formulations.
Key Market Trends
Integration of Plant-Based Excipients in Biologics and Biosimilars
The expanding biologics and biosimilars sector is catalyzing a key trend: the integration of plant-based excipients into advanced drug formulations. Biologic therapies-such as monoclonal antibodies and vaccines-require excipients that provide enhanced stability, solubility, and controlled release. Plant-derived polysaccharides like HPMC, xanthan gum, and pectin are gaining traction due to their ability to meet these needs. These natural excipients are proving particularly useful in developing subcutaneous and oral delivery formats for biologics, aligning with patient-centric care trends. Supportive government initiatives, such as NIH and IMI research funding, are accelerating innovation in excipient technologies. As biologics become more mainstream and patient demand for non-invasive administration rises, plant-based excipients are positioned as a viable, sustainable solution to support next-generation drug development.
In this report, the Global Plant Based Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Plant Based Excipients Market.
Global Plant Based Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: